![](/img/cover-not-exists.png)
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Lakshminarayanan, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., Boons, G.-J.Volume:
109
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1115166109
Date:
January, 2012
File:
PDF, 173 KB
english, 2012